Pfizer Ltd.

4,509.2

-63.7 (-1.4%)stock indicator image for downward trend

As on June 12, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap20,641 Cr
P/E Ratio26.88
Dividend Yield0.37 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open4,555
High4,578.1
NSE SymbolPFIZER
Close4,509.2
Low4,501
BSE Symbol500680
Previous Years High/Low
1 Year High5,993
3 Year High6,451.15
5 Year High6,451.15
1 Year Low4,396.7
3 Year Low3,701
5 Year Low3,408

Technicals


IndicatorsValueSignal
5-DMA4,548.06Bearish
10-DMA4,511.43Bearish
20-DMA4,613.77Bearish
50-DMA4,721.56Bearish
100-DMA4,763.03Bearish
200-DMA4,938.98Bearish

Historical Performance


1 Year
-23.4%
3 Years
15.8%
5 Years
-18.6%
10 Years
143.3%

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsNov-2008Nov-2007Nov-2005Nov-2004
Net Sales7,3687,3666,7486,469
Total Expenditure5,8565,8015,5885,562
Other Income7113,218332141
Operating Profit2,2234,7831,4921,048
Interest------28
Depreciation11196138103
Profit Before Tax4,1914,5131,119745
Consolidated Net Profit2,9963,400707446
Adjusted EPS1001142415
Compounded Sales Growth
10 Years:4.2
5 Years:1.2
3 Years:-2.7
TTM:0.8
Compounded Profit Growth
10 Years:50.2
5 Years:8.6
3 Years:4.6
TTM:6.8
Stock Price CAGR
10 Years:9.4
5 Years:-4
3 Years:5.4
TTM:-23.4
Return on Equity
10 Years:66.7
5 Years:108.8
3 Years:136.4
last year:167.8

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 26.88, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a moderate 3-year price CAGR of 5.4%, reflecting average market performance.
  • The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹9126 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹22814 million, indicating a large and established business.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 766544.8
No. of Shares: 170 (Approx)
Performance:-23.3%
P/L: ₹-233455.2
NIFTY Performance: -4.4%
1 day Top Gainers
SymbolChange%
IFCI84.57(20%)
AIIL530.15(15%)
TTML46.44(10%)
ASHOKLEY152.45(10%)
NETWEB4587.4(9%)
1 Day Top Losers
SymbolChange%
NESTLEIND1375.7(-3%)
OIL417.8(-3%)
ONGC246.2(-3%)
TECHM1429.2(-3%)
ONESOURCE1612.5(-2%)
INOXINDIA1808.2(-2%)
PREMIERENE1034.6(-2%)
IPCALAB1583(-2%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

92.9%

1797.5

1 Month Performance

Bliss GVS Pharma Ltd.

59.9%

437.85

1 Month Performance

Panacea Biotec Ltd.

46.6%

536

1 Month Performance

Sakar Healthcare Ltd.

44.7%

824.1

1 Month Performance

Supriya Lifescience Ltd.

44.6%

977.15

1 Month Performance

Rubicon Research Ltd.

39.6%

1295.5

1 Month Performance

NGL Fine-Chem Ltd.

39.3%

3048.8

1 Month Performance

Senores Pharmaceuticals Ltd.

38.3%

1290

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month